Galapagos, Cellzome Forge Kinase Drug Discovery Partnership | GenomeWeb
NEW YORK (GenomeWeb News) - Galapagos and Cellzome today said that they are collaborating in kinase drug discovery. 
Under the terms of the agreement, Galapagos' service division BioFocus DPI will provide its SoftFocus kinase libraries to Cellzome. BioFocus will also provide biological screening and chemistry expertise to find inhibitors of Cellzome's kinase targets, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.